Related Experiment Video

Updated: Aug 12, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

CpG-island methylation and epigenetic control of resistance to chemotherapy

J M Teodoridis1, G Strathdee, J A Plumb

  • 1Centre for Oncology and Applied Pharmacology, Cancer Research UK Beatson Laboratories, University of Glasgow, Glasgow, UK.

Biochemical Society Transactions
|October 28, 2004
PubMed

Insights

Aberrant DNA methylation silences tumor suppressor genes, impacting chemotherapy sensitivity and resistance. Epigenetic profiling can guide personalized epigenetic therapies for cancer treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Aberrant methylation of CpG islands silences genes crucial for tumor development.
  • Epigenetic silencing of DNA damage response genes affects cancer cell sensitivity to chemotherapy.
  • Chemotherapy can induce acquired chemoresistance by selecting for epigenetically silenced drug sensitivity genes.

Purpose of the Study:

  • To investigate the role of aberrant DNA methylation in cancer.
  • To understand how epigenetic silencing influences chemotherapy response.
  • To explore the potential of epigenetic profiling in guiding cancer therapy.

Main Methods:

  • Analysis of DNA methylation patterns in tumor samples.
  • Assessment of gene expression in relation to methylation status.
  • Correlation of epigenetic profiles with clinical chemotherapy outcomes.

Main Results:

  • Tumor development is associated with aberrant methylation and transcriptional inactivation of key genes.
  • Epigenetic silencing of DNA damage response pathways can alter intrinsic tumor sensitivity to chemotherapy.
  • Chemotherapy can lead to acquired resistance through selection of epigenetically modified cell subpopulations.

Conclusions:

  • Aberrant DNA methylation plays a significant role in cancer development and chemoresistance.
  • Epigenetic profiling is valuable for optimizing combination therapies.
  • Identifying patient populations who benefit from epigenetic therapies is crucial.

More Related Videos

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...